The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Borrower

T••• P••••••••• F•••••• N••••••••• I••• B•

group grade Aon a schedule nowsponsor unattributed
Also written as: Teva Pharmaceutical Finance Netherlands III B.V
Principal held
at least $1.0M
sum of BDC pieces, a lower bound
Fair value
$996,000
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 1, 2026
$1.0M inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
other lien unstatedat least $1.0M100cS+315 bpOct 1, 20261
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
B••••••••• P•••••• C••••• F•••unstated lien unstated
Non-Affiliated Issuer
$1.0M$996,000
100c
S+315 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$1.0M$996,000100c0
Mar 31, 20261$1.0M$991,000100c0
Dec 31, 20251$1.0M$991,000101c0
Sep 30, 20251$1.0M$983,000100c0
Jun 30, 20251$1.0M$981,000101c0
Mar 31, 20251$1.0M$970,000100c0
Dec 31, 20241$2.0M$1.9M100c0
Sep 30, 20241$1.0M$962,000100c0
What changed
Every change including routine ones
Identity
Group key
TEVA PHARMACEUTICAL FINANCE NETHERLANDSderivedthe codename stem after legal suffixes and deal words
Spellings
2 across 1 BDCderived